Decline in Big Pharma Deal Activity Mirrors Industry-wide Slowdown in Dealmaking
By Jawala Prasad & Jasmine Kalsi
Pharma Deals Review: Vol 2018 Issue 12 (Table of Contents)
Published: 28 Dec-2018
DOI: 10.3833/pdr.v2018.i12.2388 ISSN: 1756-7874
Section: Opinion & Analysis
Fulltext:
Abstract
Dealmaking is still an important and necessary means for companies to access innovation and sustain revenues in their therapeutic areas of focus...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.
Login Problems
RSS